Top compounds associated with response to MT3


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.11 0.002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA DMOG GDSC1000 pan-cancer AAC -0.1 0.002
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.11 0.002
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA FK866 GDSC1000 pan-cancer AAC 0.091 0.002
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC 0.12 0.002
Download CSV